Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
The European Journal of Neuroscience|March 11, 2000
Specific activation of the mu opioid receptor (MOR) by endomorphin 1 and endomorphin 2K Monory, M C Bourin, M Spetea, et al.Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1995
Opioid antagonist properties of the highly delta-receptor-selective BOC-Tyr-Pro-Gly-Phe-Leu-Thr (OtBu) peptide and of its Phe1 and Mel1 analoguesA Z Rónai, A Magyar, G Orosz, et al.Biochemical and Biophysical Research Communications|January 10, 2002
Side chain modifications change the binding and agonist properties of endomorphin 2I Lengyel, G Orosz, D Biyashev, et al.Neurochemical Research|September 1, 1994
Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor bindingQ Ni, H Xu, J S Partilla, et al.European Journal of Pharmacology|December 11, 1999
Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assaysA Márki, K Monory, F Otvös, et al.British Journal of Pharmacology|November 6, 2007
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and toleranceB Aguila, L Coulbault, M Boulouard, et al.The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Development of delta-opioid receptor subtypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridization studiesI Kitchen, F M Leslie, M Kelly, et al.Biology of Reproduction|March 19, 2010
Nociceptin inhibits uterine contractions in term-pregnant rats by signaling through multiple pathwaysA Klukovits, K Tekes, O Gündüz Cinar, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cellsM M Belcheva, S Gucker, D M Chuang, et al.Current Medicinal Chemistry|September 1, 2012
A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacyE Lacko, A Varadi, R Rapavi, et al.Pageof 10